An announcement from GlaxoSmithKline ( (GB:GSK) ) is now available.
GSK has filed its 2024 Annual Report on Form 20-F with the SEC, which includes audited financial statements for the year ending December 31, 2024. The report is accessible online, and shareholders can request a hard copy. This filing is a routine disclosure that provides transparency and accountability to shareholders and stakeholders, reinforcing GSK’s commitment to regulatory compliance and financial transparency.
More about GlaxoSmithKline
GSK is a global biopharma company focused on uniting science, technology, and talent to advance in disease prevention and treatment.
YTD Price Performance: 10.14%
Average Trading Volume: 7,985,177
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: £59.81B
For a thorough assessment of GSK stock, go to TipRanks’ Stock Analysis page.